3,862
Participants
Start Date
March 11, 2019
Primary Completion Date
August 6, 2020
Study Completion Date
August 6, 2020
AV7909
AV7909 consists of Anthrax Vaccine Adsorbed (AVA) drug substance and CPG 7909 adjuvant. AVA drug substance in AV7909 is similar in composition and manufactured using the same process as commercial BioThrax® vaccine. BioThrax is licensed for post-exposure prophylaxis of anthrax disease. CPG 7909 is an immunostimulatory synthetic oligodeoxynucleotide that functions as an adjuvant. It is designed to induce an enhanced immune response.
BioThrax
BioThrax vaccine (Anthrax Vaccine Adsorbed; AVA) is licensed for post-exposure prophylaxis of anthrax disease.
Optimal Research, LLC, Rockville
Spartanburg Medical Research, Spartanburg
Coastal Carolina Research Center, Inc, Mt. Pleasant
Meridian Clinical Research, LLC, Savannah
Optimal Research, LLC, Melbourne
Research Centers of America, Hollywood
New Horizon Research Center, Inc, Miami
Achieve Clinical Research, LLC, Birmingham
Optimal Research, LLC, Huntsville
Coastal Clinical Research, an AMR company, Mobile
Clinical Research Associates, Inc., Nashville
Aventiv Research Inc., Grove City
Rapid Medical Research, Inc., Cleveland
The Iowa Clinic, PC, West Des Moines
Optimal Research, LLC, Peoria
Christie Clinic, LLC, Champaign
The Center for Pharmaceutical Research, an AMR company, Kansas City
Johnson County Clin-Trials, LLC, Lenexa
Heartland Research Associates, LLC, Augusta
Heartland Research Associates, LLC, Wichita
Hutchinson Clinic, Hutchinson
Meridian Clinical Research, LLC, Omaha
Benchmark Research New Orleans, Metairie
Lynn Institute of Norman, Norman
Benchmark Research, Fort Worth
Benchmark Research San Angelo, San Angelo
Martin Diagnostic Clinic, Tomball
Tekton Research, Austin
Advanced Clinical Research, Boise
Advanced Clinical Research, West Jordan
Central Phoenix Medical Clinic, LLC, Phoenix
Clinical Research Consortium, an AMR company, Tempe
Clinical Research Center of Nevada LLC, Las Vegas
California Research Foundation, San Diego
Optimal Research, LLC, San Diego
Lead Sponsor
Biomedical Advanced Research and Development Authority
FED
Emergent BioSolutions
INDUSTRY